“We want to be in every clinic”: The Israeli startup out to change early disease detection
09.06.25 | Amy Shapiro
Backed by Google, the EU, and the IIA, NaNose Medical is pioneering non-invasive, breath-based diagnostics to close the gap in early detection of liver and lung cancer. As it approaches its Series A, co-founder and COO Ilay Marom says the Israeli startup is already eyeing real-world deployment and commercialization.